The central renin-angiotensin system participates in the regulation of arterial pressure and fluid balance. Since neuronal, glial and vascular elements within the central nervous system (CNS) all express high affinity angiotensin (Ang) receptors, it is not clear how these components interact to bring about this regulation. However, we have evidence suggesting that astrocytes may be responsible for many of the central effects of the renin- angiotensin system. We have shown that cultured human astrocytes produce and secrete angiotensinogen (Aogen). Furthermore, we have recently demonstrated that Aogen secretion can be regulated by Ang II in a region- specific manner. In addition, we have detected the presence of multiple Ang receptor subtypes on astrocytes that are distinguishable by the cellular signals they elicit, their selectivity for Ang peptides, and their inhibition by subtype selective receptor antagonists. For example, Ang II and Ang-(2-8) mobilize intracellular Ca2+ by activation of a phosphoinositide-specific phospholipase C while Ang II and Ang-(1-7) release prostaglandins via a Ca2+-independent pathway. Since prostaglandins display many of the same cardiovascular effects as Ang II and have recently been suggested as the mechanism by which Ang II causes vasopressin release, we hypothesize that many of the known actions of angiotensin peptides in the CNS are mediated by effects of astrocyte functions. Because transformed astrocytes were used to generate the above information, we must now clearly demonstrate that non-transformed astrocytes express Ang peptide receptor subtypes and produce distinct cellular signals. We will therefore identify Ang peptide binding sites, their activation of specific signal transduction mechanisms and their role in expression of Aogen mRNA in primary cultures of astrocytes from rat brain. Furthermore, to determine whether Ang peptide receptors on astrocytes are involved in the central control of blood pressure and cardiovascular function, we will isolate astrocytes from brain areas which are known to participate in the regulation of blood pressure and study expression of Ang peptide receptors and their cellular responses in cultured astrocytes from these specific regions. We will then be able to relate our findings to the known location of brain areas involved in blood pressure regulation and design physiological studies to elucidate the potential involvement of Ang peptide receptors on astrocytes in cardiovascular function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS031664-02
Application #
3418608
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1992-08-01
Project End
1995-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Clark, Michelle A; Tallant, E Ann; Tommasi, Ellen et al. (2003) Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism. J Cardiovasc Pharmacol 41:276-83
Tallant, E Ann; Clark, Michelle A (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42:574-9
Clark, M A; Diz, D I; Tallant, E A (2001) Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension 37:1141-6
Clark, M A; Tallant, E A; Diz, D I (2001) Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7). J Cardiovasc Pharmacol 37:437-48
Strawn, W B; Ferrario, C M; Tallant, E A (1999) Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33:207-11
Tallant, E A; Lu, X; Weiss, R B et al. (1997) Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 29:388-93
Tallant, E A; Higson, J T (1997) Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia 19:333-42
Freeman, E J; Chisolm, G M; Ferrario, C M et al. (1996) Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28:104-8
Tallant, E A; Diz, D I; Ferrario, C M (1996) Identification of AT1 receptors on cultured astrocytes. Adv Exp Med Biol 396:121-9
Freeman, E J; Ferrario, C M; Tallant, E A (1995) Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens 8:1105-11

Showing the most recent 10 out of 11 publications